Notice to Stakeholders: Questions and Answers on Regulatory Expectations for Medicinal Products for Human Use During the COVID-19 Pandemic
The European Commission, European Medicines Agency and the European medicines regulatory network have developed a question-and-answer document to provide guidance to stakeholders on adaptations to the regulatory framework to address challenges arising from the COVID-19 pandemic. The document was fir...
| Autor principal: | |
|---|---|
| Formato: | article |
| Idioma: | por |
| Publicado em: |
2020
|
| Texto completo: | https://doi.org/10.25756/rpf.v12i1-2.244 |
| País: | Portugal |
| Oai: | oai:ojs.farmacoterapia.pt:article/287 |